Where does Rory Collins practice?

Rory Collins is affiliated with University of Oxford in United Kingdom.

What is Rory Collins's H-index?

Rory Collins has an H-index of 315, placing them in the top 0.01% of medical professionals worldwide.

What is Rory Collins's medical specialty?

Rory Collins specializes in Clinical Trial Methodology.

Is Rory Collins verified by MDRPedia?

Yes, Rory Collins is a verified TITAN tier physician on MDRPedia, the global authority for medical reputation.

Rory Collins — MDRPedia

Top 0.01% — Titan Top 100 (#33)

Rory Collins

Clinical Trial Methodology

United Kingdom

315 H-Index

5,590 Total Impact

Share or Embed Profile

Profile URL

Quick Share

Embed Style

Minimal link badge for your website

<a href="https://mdrpedia.com/doctors/rory-collins" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:8px 16px;background:#1a1a2e;border:1px solid rgba(255,255,255,0.1);border-radius:8px;text-decoration:none;color:#fff;font-family:system-ui,sans-serif;font-size:14px;"><span style="color:#ffd700;">●</span>Rory Collins — MDRPedia</a>

Preview:

● Rory Collins — MDRPedia

Copied!

Overview

Rory Collins is a clinical trial methodology specialist with an H-index of 315 at University of Oxford (Faculty). Has been published in The Lancet, New England Journal of Medicine, JAMA. Based in United Kingdom.

Biography

Sir Rory Edwards Collins FMedSci FRS is a British physician who is professor of medicine and epidemiology at the Clinical Trial Service Unit within the University of Oxford, the head of the Nuffield Department of Population Health and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies ("meta-analyses"). Since September 2005, he has been the Principal Investigator and Chief Executive of the UK Biobank, a prospective study of 500,000 British people aged 40–69 at recruitment.